POCT for Sexually Transmitted Infections

Kryptos Biotechnology, with support from the RIGHT Foundation, is developing the Kuick™ system, a rapid, multiplex qPCR-based point-of-care (POC) diagnostic platform to address STI underdiagnosis in LMICs. Limited access to screening and diagnostics leads to untreated STIs, increasing risks of infertility, pregnancy complications, cancers, and HIV infection. The Kuick™ system uses ultrafast photonic qPCR technology, delivering highly sensitive, multiplexed STI results (CT/NG/TV) in under 30 minutes, surpassing current POC tests in speed, cost, and performance. Its battery-operated design, solid-phase extraction, and connectivity with HL7 messaging ensure accessibility and seamless integration into LMIC healthcare systems. With WHO prioritizing CT/NG/TV testing in its Global Health Sector Strategies (GHSS) 2022-2030, this platform aligns with global STI elimination goals. By enabling timely and accurate STI diagnosis, Kuick™ will improve treatment outcomes, reduce transmission, and significantly impact reproductive health in high-burden regions.